Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Franzin L et al. |
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. |
2000 |
Curr. Microbiol. |
pmid:10594221
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Komatsu H et al. |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. |
1999 |
Br. J. Dermatol. |
pmid:10583068
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Tanigawara Y et al. |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10579481
|
de Luis DA et al. |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. |
1999 |
Clin Nutr |
pmid:10578022
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Mach T and Zahradnik-Bilska J |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. |
1999 |
Prz. Lek. |
pmid:10575912
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Adeyemi EO et al. |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10563537
|
MartÃn de Argila C and Boixeda D |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection]. |
1999 |
Med Clin (Barc) |
pmid:10562929
|
Valencia IC et al. |
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. |
1999 |
Int. J. Dermatol. |
pmid:10561050
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Hammett DC and Evans MF |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? |
1999 |
Can Fam Physician |
pmid:10540692
|
Gisbert JP et al. |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10540045
|
Saito H et al. |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice]. |
1999 |
Kekkaku |
pmid:10535281
|
Gonzalez Cueto D et al. |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. |
1999 |
Acta Gastroenterol. Latinoam. |
pmid:10533659
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Gibson JR et al. |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. |
1999 |
J. Clin. Microbiol. |
pmid:10523591
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Goldberg EI et al. |
Henoch-Schönlein purpura induced by clarithromycin. |
1999 |
Int. J. Dermatol. |
pmid:10517691
|
Foster SF et al. |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat. |
1999 |
J Small Anim Pract |
pmid:10516950
|
Rovira E et al. |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. |
1999 |
Respiration |
pmid:10516537
|
Gilljam M et al. |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. |
1999 |
Eur. Respir. J. |
pmid:10515412
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Galil K et al. |
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. |
1999 Sep-Oct |
Emerging Infect. Dis. |
pmid:10511524
|
Furuta T et al. |
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10511062
|
McMullin ST et al. |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. |
1999 |
Arch. Intern. Med. |
pmid:10510994
|
Uygun A et al. |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
1999 |
Clin Ther |
pmid:10509849
|
Gisbert JP et al. |
Re-treatment after Helicobacter pylori eradication failure. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503846
|
Bazzoli F et al. |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503822
|
Mégraud F |
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503821
|
Spiller RC |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503819
|
Unge P |
The OAC and OMC options. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503817
|
Gómez G et al. |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin. |
1999 |
Transplant. Proc. |
pmid:10500563
|
Landesman KA et al. |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. |
1999 |
Conn Med |
pmid:10500341
|
Zgoulli S et al. |
Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. |
1999 Sep-Oct |
J Microencapsul |
pmid:10499837
|
Ellenrieder V et al. |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. |
1999 |
Scand. J. Gastroenterol. |
pmid:10499474
|
Hirsh DC and Jang SS |
Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. |
1999 |
J. Am. Vet. Med. Assoc. |
pmid:10496134
|
Osato MS et al. |
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10493611
|
Moore PA |
Dental therapeutic indications for the newer long-acting macrolide antibiotics. |
1999 |
J Am Dent Assoc |
pmid:10492541
|
Gutiérrez-Cabano CA and Raynald AC |
Gastroprotective effect of intragastric clarithromycin against damage induced by ethanol in rats. |
1999 |
Dig. Dis. Sci. |
pmid:10492159
|
RodrÃguez Téllez M et al. |
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. |
1999 |
Rev Esp Enferm Dig |
pmid:10491487
|
Tyagi AK et al. |
An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis. |
1999 |
Cornea |
pmid:10487437
|
Matsuoka M et al. |
Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure. |
1999 |
Gut |
pmid:10486356
|
Klapper SR and Patrinely JR |
Periocular atypical mycobacterial infections. |
1999 |
Ophthalmology |
pmid:10485521
|
Gidoh M |
[The control leprous peripheral neuropathy and chemotherapy]. |
1999 |
Nihon Hansenbyo Gakkai Zasshi |
pmid:10481449
|
Sato K et al. |
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines]. |
1999 |
Kekkaku |
pmid:10481412
|
Gómez Cubillos C et al. |
[Can macrolide treatment delay the diagnosis of tuberculosis?]. |
1999 |
An Med Interna |
pmid:10481348
|
Geiderman JM |
Central nervous system disturbances following clarithromycin ingestion. |
1999 |
Clin. Infect. Dis. |
pmid:10476775
|
Mikamo H et al. |
Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. |
1999 Sep-Oct |
Chemotherapy |
pmid:10473928
|
Tanaka E et al. |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. |
1999 |
Am. J. Respir. Crit. Care Med. |
pmid:10471610
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Kamada T et al. |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin. |
1999 |
Helicobacter |
pmid:10469195
|
Catalano F et al. |
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. |
1999 |
Helicobacter |
pmid:10469192
|
Sung JJ et al. |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468684
|
Paré P et al. |
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468683
|
Gschwantler M et al. |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468682
|
Gooderham MJ et al. |
Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin. |
1999 Jul-Aug |
Ann Pharmacother |
pmid:10466907
|
Sendi PP et al. |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study. |
1999 |
J Eval Clin Pract |
pmid:10461580
|
Boyanova L et al. |
Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10459482
|
Labenz J and Stolte M |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?]. |
1999 |
Z Gastroenterol |
pmid:10458014
|
Härtig G et al. |
[Symptomatic psychosis in bland sinus thrombosis and antibiotic therapy]. |
1999 |
Psychiatr Prax |
pmid:10457975
|
Pandita D and Carson PJ |
Thyroid abscess caused by Mycobacterium chelonae. |
1999 |
Clin. Infect. Dis. |
pmid:10452671
|
Gordin FM et al. |
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. |
1999 |
Clin. Infect. Dis. |
pmid:10452638
|
Anzueto A et al. |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis. |
1999 |
Clin. Infect. Dis. |
pmid:10451195
|
Enroth H et al. |
Occurence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: a potential risk in clarithromycin-based therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10451171
|
Hewitt RG et al. |
Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. |
1999 |
AIDS |
pmid:10449290
|
Ali' A et al. |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. |
1999 |
Am. J. Gastroenterol. |
pmid:10445583
|
Bazzoli F |
My approach to Helicobacter pylori eradication. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10443911
|
Shimada N et al. |
[A case of acute renal failure with rhabdomyolysis caused by the interaction of theophylline and clarithromycin]. |
1999 |
Nihon Jinzo Gakkai Shi |
pmid:10441997
|
Lipsky BA et al. |
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. |
1999 |
Clin Ther |
pmid:10440620
|
Cohn DL et al. |
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. |
1999 |
Clin. Infect. Dis. |
pmid:10433575
|
Schmitt H et al. |
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. |
1999 |
Clin. Infect. Dis. |
pmid:10433574
|
Baena DÃez JM et al. |
[Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size]. |
1999 |
Rev Clin Esp |
pmid:10432821
|
Owen RJ et al. |
Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients. |
1999 |
Microb. Drug Resist. |
pmid:10432275
|
Kyzekova J and Mour J |
The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. |
1999 May-Jun |
Hepatogastroenterology |
pmid:10430396
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Grimm KJ |
Treatment of Helicobacter pylori infection in functional dyspepsia. |
1999 |
J Fam Pract |
pmid:10428242
|